Outcome | Not on anticoagulation (n = 828) | On anticoagulation (n = 120) | p-value |
---|---|---|---|
Best overall response—no. (%) | 0.80 | ||
Complete response (CR) | 129 (15.6) | 14 (11.7) | |
Partial response (PR) | 140 (16.9) | 23 (19.2) | |
Stable disease (SD) | 144 (17.4) | 22 (18.3) | |
Progressive disease (PD) | 395 (47.7) | 60 (50.0) | |
Could not be evaluated | 10 (1.2) | 1 (0.8) | |
Objective response ratea | 0.60 | ||
No. (%) | 279 (33.6) | 37 (30.8) | |
95% CIb | 30.4–37.0 | 22.7–40.0 | |
Disease control ratec | 0.77 | ||
No. (%) | 423 (51.1) | 59 (49.2) | |
95% CIb | 47.6–54.5 | 40.0–58.4 |